- Home
- EXAS vs ATR Comparison
EXAS vs ATR Comparison
Compare EXAS & ATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- ATR
- Stock Information
- Founded
- EXAS 1995
- ATR 1992
- Country
- EXAS United States
- ATR United States
- Employees
- EXAS N/A
- ATR N/A
- Industry
- EXAS Medical Specialities
- ATR Plastic Products
- Sector
- EXAS Health Care
- ATR Industrials
- Exchange
- EXAS Nasdaq
- ATR Nasdaq
- Market Cap
- EXAS 8.6B
- ATR 9.3B
- IPO Year
- EXAS N/A
- ATR 1993
- Fundamental
- Price
- EXAS $53.81
- ATR $138.54
- Analyst Decision
- EXAS Strong Buy
- ATR Strong Buy
- Analyst Count
- EXAS 22
- ATR 5
- Target Price
- EXAS $66.43
- ATR $184.00
- AVG Volume (30 Days)
- EXAS 3.4M
- ATR 445.1K
- Earning Date
- EXAS 11-04-2025
- ATR 10-23-2025
- Dividend Yield
- EXAS N/A
- ATR 1.30%
- EPS Growth
- EXAS N/A
- ATR 21.86
- EPS
- EXAS N/A
- ATR 5.79
- Revenue
- EXAS $2,939,949,000.00
- ATR $3,610,693,000.00
- Revenue This Year
- EXAS $16.50
- ATR $4.33
- Revenue Next Year
- EXAS $12.32
- ATR $5.08
- P/E Ratio
- EXAS N/A
- ATR $23.92
- Revenue Growth
- EXAS 12.55
- ATR 1.51
- 52 Week Low
- EXAS $38.81
- ATR $130.85
- 52 Week High
- EXAS $72.83
- ATR $178.03
- Technical
- Relative Strength Index (RSI)
- EXAS 71.11
- ATR 40.89
- Support Level
- EXAS $46.30
- ATR $134.44
- Resistance Level
- EXAS $47.76
- ATR $140.57
- Average True Range (ATR)
- EXAS 1.51
- ATR 2.25
- MACD
- EXAS 0.99
- ATR 0.39
- Stochastic Oscillator
- EXAS 94.30
- ATR 46.12
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About ATR AptarGroup Inc.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (49% of sales) and the United States (32%), Aptar aims to increase its presence in Asia (11%) and Latin America (8%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.